查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1683383

全球呼吸器市場 - 2025-2033

Global Ventilators Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球呼吸器市場規模達到 60.6 億美元，預計到 2033 年將達到 183.5 億美元，2025-2033 年預測期內的複合年成長率為 11.7%。

全球呼吸器市場在呼吸護理中至關重要，為患有慢性阻塞性肺病、肺炎和急性呼吸窘迫症候群等疾病的患者提供救生支持。它根據移動性、類型、介面和最終用戶進行細分，其中重症監護和攜帶式呼吸機是主要類別。飛利浦醫療、美敦力和通用電氣醫療等領先公司佔據市場主導地位，而 SCHILLER Healthcare 和 Ventis Medical Inc. 等新興公司則推出了創新解決方案。由於技術進步、呼吸系統疾病的增加以及對非侵入性通氣的需求不斷成長，市場持續擴大。

市場動態：

促進因素與約束因素

呼吸系統疾病發生率上升

全球呼吸器市場受到慢性阻塞性肺病、氣喘、急性呼吸窘迫症候群和肺炎等呼吸系統疾病發病率上升的推動，而空氣污染、吸菸和人口老化等因素則推動了這一市場的發展。 COVID-19 疫情凸顯了醫院、家庭護理和緊急護理對呼吸機的需求，從而加速了市場成長並解決了嚴重的呼吸窘迫。

例如，根據 NCD 聯盟的數據，慢性呼吸道疾病 (CRD) 是與肺部相關的疾病，在世界各地導致大量發病率和死亡率。常見的慢性阻塞性肺病 (CRD) 包括慢性阻塞性肺病 (COPD)、氣喘、肺癌和職業性肺病。這些疾病影響全球至少 5,500 億成年人，佔所有死亡人數的 7%。肺癌每年導致另外14億人死亡。

五歲以下的兒童特別容易受到肺部疾病的影響，包括肺炎等急性傳染病和氣喘等慢性病。氣喘是最常見的慢性病，​​影響全球 14% 的兒童。此外，根據美國疾病管制與預防中心的報告，2024 年 10 月 1 日至 11 月 30 日期間，因 RSV 住院的人數為 17,000 至 34,000 人。

嚴格的監管環境和合規要求

呼吸器市場面臨嚴格的監管框架、廣泛的測試、臨床試驗和認證流程的挑戰，這可能會延遲上市時間並增加成本。製造商必須適應不斷發展的標準，這可能會阻礙創新並使產品發布複雜化，從而抑制市場成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 呼吸系統疾病發生率上升
      • 科技進步的崛起
    • 限制
      • 嚴格的監管環境和合規要求
      • 新興地區醫療基礎設施有限
    • 機會
      • 居家護理通風設備的擴展
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 管道分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：按類型

  • 成人呼吸器
    • 兒科呼吸機
    • 新生兒/嬰兒呼吸器
  • 按移動方式
  • 重症監護呼吸機
  • 攜帶式/可移動式呼吸機

第 7 章：按介面

  • 侵入性通氣
  • 非侵入性通氣

第 8 章：按最終用戶

  • 醫院和診所
  • 家庭護理設置
  • 門診護理中心
  • 緊急醫療服務（EMS）

第9章：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Philips Healthcare
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • ResMed Inc
  • Medtronic plc
  • GE Healthcare
  • Dragerwerk AG & Co. KGaA
  • Hamilton Medical AG
  • Fisher & Paykel Healthcare Corporation Limited
  • Getinge AB
  • Vyaire Medical
  • AgVa Healthcare
  • Similar data will be provided for each market player.
  • SCHILLER Healthcare India 私人有限公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • Biovo 技術有限公司
  • 布雷斯醫療公司
  • Enexor 生物能源有限責任公司
  • 將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄
Product Code: MD9321

The global ventilators market reached US$ 6.06 billion in 2024 and is expected to reach US$ 18.35 billion by 2033, growing at a CAGR of 11.7% during the forecast period 2025-2033.

The global ventilators market is vital in respiratory care, providing life-saving support to patients with conditions like COPD, pneumonia and ARDS. It is segmented based on mobility, type, interface, and end-users, with intensive care and portable ventilators being key categories. Leading companies like Philips Healthcare, Medtronic and GE Healthcare dominate the market while emerging players like SCHILLER Healthcare and Ventis Medical Inc. introduce innovative solutions. The market continues to expand due to technological advancements, rising respiratory diseases, and the growing demand for non-invasive ventilation.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Respiratory Diseases

The global ventilators market is driven by the rise in respiratory diseases like COPD, asthma, ARDS, and pneumonia, driven by factors like air pollution, smoking, and aging populations. The COVID-19 pandemic underscored the need for ventilators in hospitals, home care, and emergency care, accelerating market growth and addressing severe respiratory distress.

For instance, according to the NCD Alliance, Chronic respiratory diseases (CRDs) are lung-related diseases that cause significant morbidity and mortality worldwide. Common CRDs include COPD, asthma, lung cancer, and occupational lung diseases. These diseases affect at least 550 Billion adults globally and account for 7% of all deaths. Lung cancer contributes to another 1.4 Billion deaths annually.

Children under five years of age are particularly affected by lung diseases, including acute infectious diseases like pneumonia and chronic conditions like asthma. Asthma is the most common chronic condition, affecting 14% of children globally. Moreover, according to the Centers for Disease Control and Prevention reports between October 1 and November 30, 2024, there were between 17,000 and 34,000 hospitalizations due to RSV.

Stringent Regulatory Environment and Compliance Requirements

The ventilators market faces challenges due to strict regulatory frameworks, extensive testing, clinical trials, and certification processes, which can delay time-to-market and increase costs. Manufacturers must adapt to evolving standards, which can hinder innovation and complicate product launches, restraining market growth.

Segment Analysis

The global ventilators market is segmented based on type, mobility, interface, end user and region.

Type:

The adult ventilators in the type segment are expected to dominate the ventilators market with the highest market share

Adult ventilators are mechanical devices used to provide respiratory support to adults with breathing difficulties or respiratory failure. They deliver controlled oxygen and remove carbon dioxide, ensuring adequate gas exchange in the lungs. Commonly used in ICUs, emergency rooms, and home care for conditions like COPD, ARDS, and post-surgical recovery.

The adult ventilator market is fueled by rising respiratory diseases like COPD, ARDS, and pneumonia, as well as the geriatric population's increased susceptibility to respiratory illnesses. Moreover, product launches, technological advancements like AI integration and the development of portable and home-use ventilators are driving market growth. The increasing number of ICU admissions, awareness of critical care infrastructure, and government initiatives to strengthen healthcare systems, particularly after the COVID-19 pandemic, are also driving market expansion.

For instance, in February 2024, Getinge launched its Sewo-c mechanical ventilator in India, designed to cater to the diverse respiratory needs of both pediatric and adult patients. The launch is a significant step towards making advanced healthcare solutions accessible and affordable for hospitals across India.

Geographical Analysis

North America is expected to hold a significant position in the ventilators market with the highest market share

North America is experiencing significant growth in the ventilators market due to its advanced healthcare infrastructure, significant medical technology investment, and high demand for respiratory care solutions. Government initiatives and reimbursement policies support advanced ventilator systems, especially in critical care settings. The COVID-19 pandemic has accelerated investments in intensive care infrastructure, emphasizing the need for reliable ventilator support.

The presence of major players in the region is focussing on product launches with advancements, driving the market growth in the region. For instance, in October 2024, Nihon Kohden America, a global medical technology leader, introduced the NKV-440 Ventilator System, previously available through OrangeMed, to a wider range of healthcare providers.

Competitive Landscape

The major global players in the ventilators market include Philips Healthcare, ResMed Inc., Medtronic plc, GE Healthcare, Dragerwerk AG & Co. KGaA, Hamilton Medical AG, Fisher & Paykel Healthcare Corporation Limited, Getinge AB, Vyaire Medical and AgVa Healthcare among others.

Key Developments

  • In November 2024, CorVent Medical received FDA 510(k) clearance for its RESPOND ventilator, a cost-effective, safe, and smart ventilation system designed to improve healthcare access for healthcare systems, providers, and patients.
  • In July 2024, Air Liquide Medical Systems has introduced the Monnal TEO, a French ventilator designed for intensive care and critical care services. The ventilator, developed in collaboration with the Angers University Hospital's intensive care unit, is a pioneering addition to the company's mechanical ventilation history. The ventilator is designed to provide superior comfort and efficiency in healthcare settings.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global ventilators market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Mobility
  • 3.3. Snippet by Interface
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Respiratory Diseases
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Environment and Compliance Requirements
      • 4.1.2.2. Limited Healthcare Infrastructure in Emerging Regions
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion in Homecare Ventilation
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Adult Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Pediatric Ventilators
    • 6.2.4. Neonatal/Infant Ventilators
  • 6.3. By Mobility
  • 6.4. Introduction
    • 6.4.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 6.4.2. Market Attractiveness Index, By Mobility
  • 6.5. Intensive Care Ventilators*
    • 6.5.1. Introduction
    • 6.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.6. Portable/Transportable Ventilators

7. By Interface

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 7.1.2. Market Attractiveness Index, By Interface
  • 7.2. Invasive Ventilation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-Invasive Ventilation

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Home Care Settings
  • 8.4. Ambulatory Care Centers
  • 8.5. Emergency Medical Services (EMS)

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Philips Healthcare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. ResMed Inc
  • 11.3. Medtronic plc
  • 11.4. GE Healthcare
  • 11.5. Dragerwerk AG & Co. KGaA
  • 11.6. Hamilton Medical AG
  • 11.7. Fisher & Paykel Healthcare Corporation Limited
  • 11.8. Getinge AB
  • 11.9. Vyaire Medical
  • 11.10. AgVa Healthcare
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. SCHILLER Healthcare India Private Limited*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Biovo Technologies Ltd.
  • 11.13. Breas Medical AB
  • 11.14. Enexor BioEnergy LLC
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us